Skip to content
Simethicone
Imodium Multi-symptom (simethicone) is a small molecule pharmaceutical. Simethicone was first approved as Imodium multi-symptom relief on 1996-06-26. It is used to treat flatulence in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
Combinations
Imodium multi-symptom (generic drugs available since 2006-09-06)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Loperamide hydrochloride
+
Simethicone
Tradename
Company
Number
Date
Products
IMODIUM MULTI-SYMPTOM RELIEFJohnson & JohnsonN-021140 OTC2000-11-30
1 products, RLD, RS
Show 1 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
foster and thrive infants gas reliefOTC monograph final2023-06-12
imodiumNew Drug Application2021-09-27
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
flatulenceD005414R14.3
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
91 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hepatitis cD006526B19.210774229
Chronic hepatitis cD019698EFO_0004220B18.221283227
Liver cirrhosisD008103EFO_0001422K74.0112
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hepatitis bD00650922
InfectionsD007239EFO_000054411
Liver neoplasmsD008113EFO_1001513C22.011
Male infertilityD007248EFO_0004248N46111
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HepacivirusD01617412214
Chronic hepatitis bD019694EFO_0004197B18.11113
Chronic kidney failureD007676EFO_0003884N18.611
Renal insufficiencyD051437HP_0000083N1911
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients1212
VirusesD014780NCBITaxon_10239STY/T00511
TuberculosisD014376EFO_0000774A15-A1911
PharmacokineticsD01059911
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hiv infectionsD015658EFO_0000764B2011
HivD006678O98.711
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameSIMETHICONE
INN
Description
Simeticone (INN), also known as simethicone (USAN), is an anti-foaming agent used to reduce bloating, discomfort or pain caused by excessive gas.
Classification
Small molecule
Drug class
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CO[Si](C)(C)O[Si](C)(C)C.O=[Si]=O
Identifiers
PDB
CAS-ID8050-81-5
RxCUI
ChEMBL IDCHEMBL4297192
ChEBI ID
PubChem CID6433516
DrugBankDB09512
UNII ID
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 1,258 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
6,189 adverse events reported
View more details